Aug 26, 2019
- Treatment with buprenorphine is easier, less time consuming and far more effective for management of opioid withdrawal and OUD than standard care with clonidine, IVF, haldol and other symptomatic therapies.
- Induction with buprenorphine is easy, requires no IV or labs, and is usually accomplished in 1-2 hours....
Aug 26, 2019
- There are three MAT drugs available to treat addiction: naltrexone (brand name Vivitrol), methadone (brand names Dolophine or Methadose) & buprenorphine (brand name Suboxone, Subutex, and Sublicade).
- The only MAT drug appropriate for initiation in the ED is buprenorphine.
- Buprenorphine is a semi-synthetic opioid...
Aug 26, 2019
- Medication Assisted Treatment or (Medication for Addiction Treatment) is an important frontier in ED care of patients with Opioid Use Disorder. Naltrexone, methadone and buprenorphine are the medications approved for the treatment of OUD.
- Addiction is a disease that is widely misunderstood and rarely taught in...
Aug 26, 2019
- Addiction is widely misunderstood by the public and by many healthcare providers. It is not taught in most medical schools.
- Combating the opioid epidemic will require providers to understand Opioid Use Disorder (OUD) and its treatment.
- Addiction is a chronic, relapsing disease with extraordinarily high morbidity...
Aug 24, 2019
Author: Dave Saintsing
Educational Pearls:
- Poor sleep is an independent risk factor for development of health problems such as type 2 diabetes. A 2019 study, randomized participants to 3 groups: 9 hours of sleep, 5 hours of sleep with weekend catch-up sleep, and 5 hours of sleep without catch-up sleep. In the sleep...